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association between exposure to stressful life events and the development of later-life cognitive
dysfunction has been proposed. Several plausible neurohormonal pathways and genetic mechanisms
exist to support such an association. However, many logistical and methodological barriers must be
overcome before a defined causal linkage can be firmly established. Here the authors review recent
studies of the long-term cognitive consequences of exposures to cumulative ordinary life stressors as
well as extraordinary traumatic events leading to posttraumatic stress disorder. Suggestive effects
have been demonstrated for the role of life stress in general, and posttraumatic stress disorder in
particular, on a range of negative cognitive outcomes, including worse than normal changes with ag-
ing, Alzheimer’s disease, and vascular dementia. However, given the magnitude of the issue, well-
controlled studies are relatively few in number, and the effects they have revealed are modest in
size. Moreover, the effects have typically only been demonstrated on a selective subset of measures
and outcomes. Potentially confounding factors abound and complicate causal relationships despite
efforts to contain them. More well-controlled, carefully executed longitudinal studies are needed
to confirm the apparent association between stress and dementia, clarify causal relationships, develop
reliable antemortem markers, and delineate distinct patterns of risk in subsets of individuals.
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Study of the physiological consequences of acute and
chronic stress for a range of organ systems was launched
more than 70 years ago in pioneering work on the “general
adaptation syndrome” by Hans Selye, who borrowed the
term “stress” from physics and applied it to physiology
[1]. Since then, an ever-burgeoning body of research has
explored the interfaces among the central and autonomic
nervous, endocrine, and immune systems. Attempts to link
mind and body have established potential pathways of influ-
ence–both pathological and therapeutic–for the impact ofccess article under the CC BY-NC-ND license (http://
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changes in bodily tissues on the nervous system. More
recently a focus on the possible long-term “neurotoxic”
effects of stressful life events has been proposed [2].
The potential impact of stress on the development of de-
mentia or other forms of cognitive dysfunction may be
considered from the standpoints of the individual, the
stressor, and the stress response. People vary widely in their
ability to cope with stressful events, a quality referred to as
resilience. Factors influencing resilience include cognitive
endowment, developmental stage, substance use, mental
and physical (e.g., cardiovascular) health, and access to so-
cial support as well as a host of putative genetic and physio-
logical markers such as Apoe4 allele types and patterns of
cortisol secretion. Stressors may be categorized across
several dimensions, including intensity, duration, novelty,
and type. Examples of types of stressors include threat of
death or bodily injury, personal illness, and loss of a loved
one through illness or separation as well as more mundaneeserved.
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commuting. Variation in one’s response to a stressor involves
appraisal of danger, perceived predictability and controlla-
bility, and the potential development of psychopathology.
In 1980, recognition of the common psychopathological
effects of extremely traumatic life events such as military
combat or sexual assault led to the inclusion of a new diag-
nosis in the psychiatric nomenclature: posttraumatic stress
disorder, or PTSD. Although the appellation for this psychi-
atric condition contained, and still contains, the word
“stress,” a body of research during the past two plus decades
led by Yehuda and colleagues [3,4] has created doubt as to
whether PTSD is a proper stress disorder, in that the
pattern of hormonal findings found in PTSD does not
appear to conform to the Selye stress model, which
emphasizes hyperactivity of the hypothalamic pituitary
adrenal (HPA) cortical axis and excessive production of
the quintessential glucocorticoid stress hormone cortisol
(corticosterone in lower animals). These findings challenge
the degree to which the adverse effects of stress and
cortisol on the nervous system discussed in much of the
subsequent text apply in the case of PTSD.
In the review that follows, we summarize and critically
discuss two distinct scenarios for long-term stress-induced
cognitive changes based on the relevant human (but not ani-
mal) literature. First, we examine the possible role of cumula-
tive, chronic everyday life stressors in cognitive dysfunction
associated with aging. We conclude there is reasonable sup-
port for the role of stress in negative cognitive outcomes,
although not necessarily Alzheimer’s disease (AD). We then
review the studies to date (only two innumber) that have inves-
tigated a possible link between PTSD and AD; we conclude
that although it is suggested, this link remains unestablished.
We then examine the underlying neurophysiological substrate
for potential stress-cognition linkages, including hormonal,
neuroimaging, neuroimmunological, and neuropathological
evidence. We also discuss how molecular events inform the
debate. Finally, we call for further study of this important sci-
entific and public health issue.2. Review of selected epidemiological studies
2.1. Chronic life stress and dementia
Controlling for the numerous potential confounding
factors in studies of stress by means of subject selection
or statistical manipulation is an onerous task. Cross-
sectional studies that characterize and compare subject
samples at a single point in time are more feasible, but
they do not allow for the serial measurement of changes
in cognition over time. Long-term longitudinal studies
are limited by the choice of measures adopted at the
outset and the problem of subject attrition. Many studies
fail to include postmortem brain tissue analysis, which
is the gold standard for the diagnosis of dementia,
especially AD.Wilson and colleagues followed a cohort of more than
800 Catholic nuns, priests, and brothers with a current
mean age of 75 in a longitudinal design, with annual assess-
ment of cognitive functioning during an average of almost 5
years. The investigators focused on the stable personality
trait of “distress proneness,” as measured by the neuroticism
subscale of the Neuroticism-Extroversion-Openness (NEO)
Five-Factor Inventory. Neurocognitive tests generated
scores on several specific domains as well as a global overall
measure. Subjects highest on baseline neuroticism (who pre-
sumably experience greater stress) had twice the chance of
developing AD according to consensus clinical diagnostic
criteria. This effect could not be explained by depression
or levels of everyday cognitive activity. In addition, episodic
memory declined 10 times more in those with high versus
low neuroticism. However, this effect was not seen for work-
ing memory, semantic memory, processing speed, visuospa-
tial ability, or the global cognitive measure. Moreover, in
autopsy, distress proneness was not related to AD neuropa-
thology [5]. This partially positive study highlights the
pitfall of equating any form of cognitive decline with AD,
and the necessity of having objective confirmation via post-
mortem pathological data or reliable antemortem surrogate
markers. There was no clear explanation for the finding
that only one of several domains of cognitive acuity was
affected.
Wilson and colleagues further tested approximately 650
healthy subjects with a mean age of 80 who were screened
for the trait of neuroticism, again using the NEO Five-
Factor Inventory, and also given a battery of cognitive tests
and a clinical examination. This cohort was followed for
an average of 3 years. Fifty-five subjects received a clinical
diagnosis of AD. Those at the 90th percentile on the distress
measure had 2.7 times the risk of being diagnosed with AD
than those at the 10th percentile. Moreover, increased
distress correlated with a more rapid decline. However, at
autopsy, distress again was unrelated to markers for AD
neuropathology, although it was negatively related to cogni-
tive acuity after controlling for AD pathology. The link be-
tween distress and the diagnosis of dementia remained
after controlling for depression, levels of social and physical
activity, and recency of cognitive symptoms. Echoing their
prior work, the authors concluded that psychological distress
is associated with cognitive decline, but not specifically with
AD [6].
Peavy and colleagues performed a 3-year longitudinal
study on 52 individuals, who were either cognitively intact
or evidencing signs of mild cognitive impairment (MCI).
Subjects with existing dementia were excluded. Stress was
measured at 6-month intervals by the Life Events and Diffi-
culties Schedule, a semistructured interview that inquires
into stressful life events in 12 categories. A rating of “high
stress” was given if therewas at least one event in the preced-
ing period rated as high intensity by a professional examiner.
Subjects also underwent annual neurological and neuropsy-
chological assessments, including the Mattis Dementia
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Memory Scale. Multiple linear regression analyses were un-
dertaken with individual rates of cognitive change as the pre-
dicted variable. Age, education, gender, and mood status did
not account for a significant portion of variance. Among
those with MCI, high stress levels were associated with
accelerated cognitive decline across the Mattis Dementia
Rating Scale total and memory subscales, but not other
memory instruments. In contrast, high stress among normal
subjects was not associated with cognitive decline [7]. This
partially positive study undertaken on a small sample under-
scores the synergistic effects of high stress and existing
cognitive impairment and highlights the importance of care-
ful baseline testing, because the inadvertent inclusion of sub-
jects with MCI in ostensibly normal cohorts may introduce a
serious confound. It is possible that the 3-year follow-up
period may not have been long enough for putative stress
effects to have become manifest in the normal subjects.
The design did not rule out the possibility that coping with
eroding cognitive acuity in the MCI group was causally
related to stressful events. For example, evolving cognitive
dysfunction could hypothetically have led to financial diffi-
culties significant enough to be rated as a high-stress event in
a given subject. To the extent that this alternate direction of
causality was operating, the results reported would not sup-
port the conclusion that stress exposure causes cognitive
decline.
Johansson and colleagues followed 1462 Swedish women
in a long-term longitudinal design over 35 years. Stress was
measured by a straightforward series of questions adminis-
tered at three intervals, yielding a total score of 0 (no stress)
to 5 (frequent/constant stress). Dementia was diagnosed by
clinical examinations, reports of informants, reviews of
medical records, and administration of neuropsychological
measures at follow-up examinations carried out 7, 13, 25,
and 35 years later. During the course of the study, 11% of
the sample developed dementia. The association between
psychological stress and the incidence of dementia and its
various subtypes was analyzed using a Cox regression model
adjusted for a number of potential confounding variables
including demographic, behavioral, and other known risk
factors such as waist-to-hip ratios. There was an increased
risk of all-cause dementia associated with reports of
frequent/constant stress measured at each of three prior as-
sessments with adjusted hazard ratios (HRs) of approxi-
mately 1.6. Subjects who reported frequent/contrast stress
in two of three prior assessments had an elevated risk of
AD compared with those reporting no periods of stress. Sub-
jects reporting high stress at one, two, and three earlier pe-
riods had escalating risks of dementia (HR 5 1.1, 1.7, and
2.7, respectively) [8]. This latter finding points to a dose-
response curve for the effect of stress exposure. The
researchers concluded that there is an association between
psychological stress in middle-aged women and the subse-
quent development of dementia, and AD in particular. The
authors rightly pointed out that because brain changes inpeople who subsequently develop AD have been found
many years before symptom onset, it is possible that
evolving dementia could increase one’s vulnerability to
stress, rather than the cumulative experience of stress trig-
gering later onset of dementia. The generalizability of this
study is limited by the exclusion of male subjects.
Johansson and colleagues invited 684 surviving cohort
participants to undergo computed tomography scans of the
brain. Of these, 344 also had data on psychological distress
collected in 1968. A neurologist blind to participants’ clin-
ical characteristics rated the computed tomography scans
by visual examination as mild, moderate, or severe for white
matter lesions (WMLs), regional cortical atrophy, and other
ventricular size measurements. Women who reported
frequent or constant stress during the 5-year period before
any of the examinations in 1968, 1974, or 1980, compared
with women who reported no stress, were more likely to
have moderate to severe WMLs, multiadjusted odds ratio
(OR) 5 2.4 as well as moderate to severe temporal lobe at-
rophy, OR 5 2.5. These ORs incorporated adjustments for
multiple possible confounders such as those listed in the pre-
vious paragraph. Additionally, adjustment for depression did
not change the reported associations. The investigators
concluded that long-standing psychological stress in midlife
increases risks of cerebral atrophy and WMLs in late life.
However, they went on to point out that a causal relationship
between increased stress and brain changes cannot neces-
sarily be inferred. For example, women with a biological
propensity to subsequent brain changes may also have re-
ported more stress [9].
A recent, second follow-up article by the same group re-
ported on the same cohort with the inclusion of the most
recent follow-up data. In this analysis, the number of
psychosocial stressors in 1968 was positively associated
with a slightly increased risk of overall dementia, adjusted
HR 5 1.2, and AD, adjusted HR 5 1.2. No significant
association was found between stress levels and vascular de-
mentia (VD). Further analysis demonstrated that not only
long-standing distress levels, but also number of psychoso-
cial stressors, independently related to AD [10]. This finding
implies that the connection between stress exposure and AD
was not fully mediated by the subjects’ perceived levels of
distress and highlights the importance of capturing objective
exposure levels.
Comijs and colleagues studied a sample of 1396 Dutch
individuals from the Longitudinal Aging Study Amsterdam
cohort at two intervals 3 years apart. Cognitive testing, using
the Folstein Mini-Mental State Examination (MMSE), a
Dutch version of the Rey Auditory Verbal Learning Test,
and the Alphabet Coding Test-15, a speed of processing
measure, was performed at both assessments. Stressful life
events experienced during the 3-year prior interval were
quantified by a structured interview. Cumulative stressful
life events were not associated with performance on any of
the cognitive measures in the total sample. Subjects with
lower initial scores on the MMSE actually improved their
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increased stressful life events. When specific life events
were examined, mixed results were obtained, with some
life events (e.g., death of a child or grandchild) associated
with a decline on the MMSE, but others (e.g., illness of a
partner) associated with less decline than in those who did
not experience the stressor. There were other counterintui-
tive findings as well. For example, those subjects who re-
ported serious interpersonal conflict actually had improved
learning scores on follow-up [11]. The spotty nature of this
study’s results highlights the difficulty in making blanket
statements about the effect of stress per se on cognition.
Andel and colleagues studied the relationship between
work-related stress and dementia risk in a sample of
10,106 Swedish mono- and dizygotic twin subjects culled
from a larger twin pool. About half of the subjects were
from twin pairs, and half were twins without their co-twin.
Job stress was inferred from subjects’ past occupational ti-
tles using the Karasek-Theorell approach, a previously vali-
dated procedure that locates each job on the dimensions of
how psychologically demanding it is and how much control
the typical employee exerts over his or her work life. The
variable of “job strain” is derived from the ratio of job de-
mands to job control. Cognitive difficulties were assessed
via telephone screening and in-person interviews using
consensus diagnostic criteria. The investigators also
measured social support as a moderating variable. The pres-
ence of AD was confirmed in 167 subjects, and VD in 46.
Mean age at dementia onset was 76.8 years. The remaining
9849 subjects served as controls. There were 60 twin pairs
represented among the demented group, 54 of which were
discordant for dementia. There were no differences in
work-stress measures in affected versus nonaffected twins.
Analysis of the entire twin sample showed that contrary to
the model, job strain did not predict overall dementia,
although the single dimension of job control did show a
weak effect, OR5 1.2, which was driven by the association
between low job control and VD, OR 5 1.4. The combina-
tion of high job strain and low social support was also signif-
icantly associated with risk of VD, OR 5 1.4. This effect
held up after accounting for age, education, sex, complexity
of work with data and people, manual versus nonmanual
work, and known vascular risk factors. This study provides
some support for the Karasek-Thorell model of occupational
stress and some suggestive data linking job-related stress to
the risk of one sub-type of dementia, such as VD. The inves-
tigators suggested that greater work stress is associated with
VD via a cardiovascular pathway, in which accelerated aging
of the cardiovascular system resulting from chronic stress
leads to earlier dementia onset [12]. An advantage of the
approach of defining stress by reference to job titles is that
it eliminates the subjectivity of retrospective self-reports of
job stress. Limitations of this study include the absence of
objective measures of cognition and autopsy data, and the
limited generalizability due to the inclusion of only subjects
who were twins.Deng and colleagues studied a sample of 5262 Chinese
subjects older than age 55, drawn from a larger pool
screened for neurological, medical, psychiatric, and sensory
impairments, for 5 years. At baseline, adverse life events
were captured by a truncated life events scale that focused
on eight common negative experiences. Cognitive function
was assessed with the MMSE; low scorers were further stud-
ied with additional neuropsychological tests. All subjects
below the threshold at baseline were excluded; additional
analyses were also undertaken to rule out the possibility of
occult cognitive dysfunction at baseline, and potential con-
founding risk factors for vascular disorders and depression.
Annual follow-up visits were carried out with repeat
MMSE and activities of daily living assessments. Results re-
vealed that experiencing the death of a spouse or a financial
crisis increased the risk of cognitive impairment. These ef-
fects were still seen after controlling for a set of known
potentially confounding variables, with an HR of approxi-
mately 1.5. However, no effects were seen for other signifi-
cant stressors such as death of an offspring, onset of a serious
illness or accident, or involvement in a lawsuit [13]. This
partially positive study extends research in this area to a
large Asian sample. A strength of the study was the system-
atic exclusion of conditions that could cause abnormal
cognitive performance at baseline.
Leng and colleagues measured childhood stressors, cu-
mulative lifetime stressors, and recent stressors as well as
coping and social support, in a cohort of 5129 British sub-
jects aged 49–90 who were participating in a prospective
epidemiological study monitoring cancer risk. Primary mea-
sures were derived from subject responses on the Health and
Life Experiences Questionnaire. These included total
adverse events experienced during the prior 5 years; number
of events involving loss; difficult childhood circumstances;
indices of impact, adaptation, and social support; and self-
perceived stress coded into five levels. Cognitive function
was assessed during a follow-up session by a modified, 11-
item short form of the MMSE. Performance was dichoto-
mously classified into high and low levels. On average, 10
years had elapsed between the stress reporting and the
assessment of cognitive acuity. After adjusting for sex and
age, MMSE scores were found to be related to the number
of loss events reported. Subjects with higher levels of self-
reported stress were more likely to have low MMSE scores,
with an increasing OR of 1.1 for each unit of increased
perceived stress. However, this effect was limited to the
highest level of perceived stress and was stronger in subjects
with lower educational attainment. In contrast, actual mea-
sures of stressful exposure per se were unrelated to MMSE
scores, as were subjects’ own estimates of the adequacy of
their adaptation/coping with experienced events [14]. This
partially positive study underscores the role of the subjective
perception of stress, and it illustrates a dose-response effect
and the role of the moderating variable of education level,
which may be a proxy for “ego-strength” or coping skills/re-
silience.
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tive results linking increased life stress to negative cognitive
outcomes, there are many caveats to the claim that adverse
life events cause cognitive decline. Typically the effect sizes,
although statistically significant, were small, with modest or
even trivial increases in relative risk. Moreover, these effects
were often seen only in selected subsamples of subjects and/
or only on selective cognitive measures. The contradictory
findings, with some studies supporting the relationship be-
tween stress and AD and others not, some studies supporting
the relationship between stress and VD but not AD, and
some studies supporting the relationship between stress
and cognitive decline but not AD or VD, preclude in our
view any disease-specific claims at this time. The frequent
absence of neuropathological analysis of tissue data further
underscores the need for caution. Continued study of this
area, however, is supported by the strongly suggestive find-
ings in the existing literature. Incorporating approaches that
use the latest consensus criteria and capture multiple aspects
of life stress, including for example exposure parameters, in-
dividual reactivity, and the role of “stress buffers,” will
improve this effort. As reliable biomarkers of specific de-
menting syndromes become better established, greater
clarity will no doubt emerge from long-term studies of the
cumulative risk of psychological stress.2.2. PTSD and dementia
Qureshi and colleagues analyzed a database of veterans
age 65 years or older who were seen at least twice at
U.S. Department of Veterans Affairs (VA) health care facil-
ities between October 1997 and September 1999, and who
either had been diagnosed with PTSD or had received a
Purple Heart (PH). PH status was used as a proxy for
combat-related trauma. These patients were compared with
age- and sex-matched, non-PTSD, non-PH VA patients.
Outpatient encounters betweenOctober 1997 and September
30, 2008, were searched for diagnoses of PTSD, dementia,
and other physical comorbidities with known associations
with dementia. The incidence of a dementia diagnosis was
6.2% in all groups: 6.8% in the PTSD1/PH1 group, 9.5%
in the PTSD1/PH2, 5.6% in the PTSD2/PH1, and 4% in
the PTSD2/PH2 group. The incidence of a dementia diag-
nosis was two times higher in the PTSD1/PH2 group
compared with both PTSD2 groups combined, adjusting
for confounding factors. The authors concluded that veterans
with PTSDhave a higher incidence of dementia thanveterans
without PTSD. However, they were careful to point out that
the observed association between PTSD and the subsequent
development of dementia does not necessarily imply a causal
relationship, in that it could also be due to common risk fac-
tors underlying both PTSD and dementia [15]. One such
common risk factor could be lower intelligence [16]. A lim-
itation was that dementia was not separated into its different
subtypes, leaving a possible association between PTSD and
any specific pathophysiological mechanism(s) potentiallyleading to the development of dementia unclear. The higher
incidence of illnesses such as hypertension and diabetes in
those with PTSD could predispose them to developing VD.
It is more difficult to postulate a pathophysiological pathway
between PTSD and neurodegenerative diseases such as AD
or Pick’s disease.
Yaffe and colleagues analyzed the VA National Patient
Care Database in a retrospective cohort design. Participants
were an impressive 181,093 veterans 55 years of age or older
who were without a dementia diagnosis from fiscal years
1997 through 2000. Of these, 53,155 had and 127,938 did
not have a PTSD diagnosis. Almost all patients (96.5%)
were men, with a mean baseline age of 69 years. During
the follow-up period between October 2000 and December
2007, 31,107 (17.2%) veterans were found to have newly
diagnosed dementia according to International Classifica-
tion of Diseases, Ninth Revision, Clinical Modification co-
des. Patients were classified with dementia if they received
one of the following diagnoses: senile dementias
(n5 3450), VD (n5 2698), AD (n5 3882), frontotemporal
dementia (n5 139), Lewy body dementia (n5 356), and de-
mentia not otherwise specified (n 5 10,291). The patients
with preexisting PTSD had a 7-year cumulative incident de-
mentia rate of 10.6%, whereas those without PTSD had a
rate of 6.6%. Patients with PTSD were more than twice as
likely to develop incident dementia compared with those
without PTSD, HR 5 2.3. After adjustments for multiple
factors, including medical and neuropsychiatric comorbid-
ities, patients with PTSD were still more likely to develop
dementia, HR 5 1.8. Results were similar after excluding
patients with a history of head injury, substance abuse, or
clinical depression. Interestingly, PTSD was associated
with all types of dementia, the strongest association being
with frontotemporal dementia, and the weakest with VD.
(Information was not provided regarding the statistical sig-
nificance of the differences of relative risks among dementia
subtypes). The authors concluded that, within the population
studied, those diagnosed with PTSD had close to two-fold
higher risk of developing dementia compared with those
without a diagnosis of PTSD [17]. Data from the previous
study illustrate an important point that is common to all
the studies of stress or PTSD and dementia reviewed in
this chapter, namely that statistical estimates alone (e.g.,
HRs or ORs) fall short of conveying the full picture. In the
previous study, approximately 90% of the PTSD patients
did not go on to develop dementia, and approximately 7%
of the non-PTSD patients did develop dementia. These per-
centages illustrate that, although PTSD may be associated
with a greater risk, it is neither a necessary nor a sufficient
condition for developing dementia—far from it.3. Substance abuse
Both exposure to chronic life stressors [18,19], and PTSD
[20] are known to be associated with an elevated risk of sub-
stance abuse. This is often thought to involve a given
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genetic data also support a common vulnerability to PTSD
and substance dependence. Either way, chronic use of sub-
stances including alcohol [21], marijuana [22], opioids
[23], cocaine [24], and methamphetamine [25] has been
linked to the development of cognitive impairment. This
pathway establishes a potential indirect mechanism for the
effects of stress, and PTSD, on cognitive integrity that needs
to be accounted for in etiological models positing a causal
relationship between stress and PTSD, and risk of dementia.4. Biology of stress, PTSD, and dementia
4.1. Neuroimaging
A longitudinal study of normal aging found a relationship
between chronic stress and decreased hippocampal andorbito-
frontal gray matter volume [26]. Structural neuroimaging
studies have revealed a lower volume of the hippocampus in
persons with PTSD [27,28]. More recent studies using high-
resolutionmagnetic resonance imaging (MRI) have identified
the CA3 and dentate gyrus subfields of the hippocampus as
showing the greatest group differences [29]. Whether the hip-
pocampal volume is a result of PTSD, a risk factor for PTSD,
or both, remains unresolved (see the following section). Other
areas that have been found to have a lower volume in PTSD
versus non-PTSD subjects, albeit less consistently and to a
lesser extent than hippocampus, are amygdala and anterior
cingulate cortex [28]. In a recent study, 42 people who
happened to have undergone MRI before an earthquake
were rescanned after it had occurred. Lower gray matter vol-
umes in the right ventral anterior cingulate cortex before the
earthquake were associated with more PTSD symptoms after
the earthquake, and greater decreases in before to after earth-
quake left orbitofrontal cortex volume were associated with
more PTSD symptoms[30].
In AD, neuroimaging has been used to track the progres-
sion of the disease from its presymptomatic to its full-blown
stage in specific and nonspecific ways. Ventricular enlarge-
ment, the most prominent radiological feature in AD, is a
nonspecific finding. In cognitively intact older adults, lower
baseline volumes of the CA1, and subiculum regions of
the hippocampus [31] as well as larger lateral ventricles
measured by MRI, predict cognitive decline to the point of
MCI. Lower volumes of CA1, subiculum, and (hypothesized
spread of atrophy to) the CA2-3 subfields of the hippocam-
pus among amnestic MCI individuals predict a future diag-
nosis of AD [32]. Additionally, lower volume of the right
caudate nucleus predicts conversion from MCI to AD [33].
Medial temporal regions including the entorhinal cortex
and amygdala are also decreased in volume in MCI patients
who later develop AD. Similarly, atrophy of the temporal
and frontal lobes, the temporoparietal cortices, anterior
and posterior cingulate gyrus, and precuneus are associated
with a 3-year progression fromMCI to AD [34]. Among AD
patients, hippocampal atrophy occurs first, followed byatrophy of the cingulum bundle and the uncinate fasciculus
[35]. Temporal, parietal, and frontal lobe atrophy worsen
with the progression of the disease [36]. Importantly, no
such progression has ever been reported in the now-
voluminous PTSD literature.4.2. Endocrine responses
In the face of adversity or threat, the body’s stress system
is activated to provide the organism the necessary resources
for a fight or flight response. Two main stress axes are
engaged in response to a stressor. First, activation of the
sympathetic-adrenal-medullary axis results in the rapid
secretion of epinephrine. Second, activation of the HPA
axis, through a chain of hormones, results in the secretion
of glucocorticoids (GCs), mainly corticosterone in lower an-
imals and cortisol in humans. GCs are liposoluble and cross
the blood–brain barrier to bind to mineralocorticoid (type I)
and glucocorticoid (type II) receptors. Type I receptors are
mainly distributed in the limbic system, whereas type II re-
ceptors are present in subcortical and cortical structures,
including the prefrontal cortex. HPA axis activity is regu-
lated by negative feedback loops, which are in part driven
by the binding of GCs to type II receptors located at the
levels of the hypothalamus and pituitary. Three brain struc-
tures have been identified as important regulators of the HPA
axis: the amygdala, which has an excitatory influence, and
the hippocampus and prefrontal cortex, which exert inhibi-
tory influences on the HPA axis. Because these brain struc-
tures have a high density of GC receptors, the functions
that they subserve are likely to be influenced by stress.
When the stress response goes unterminated, negative con-
sequences may arise, such as receptor desensitization and
tissue damage. This long-term cost of stress has been
referred to as “allostatic load [37].” Higher allostatic load
has been linked to lower cognitive functioning in older
adults [38].
The impact of stress on cognition has been studied across
various paradigms and populations. Older adults show wide
variability in hippocampal volume and function, cortisol
secretion, and cognitive performance. Many research en-
deavors have been undertaken to understand the relation-
ships among these variables, from normal to pathological
aging. Rodent studies have found that aged rats with mem-
ory impairments have higher HPA axis activity than rats
with normal memory performance [39]. In aged rats, HPA
axis activity is negatively associated with both spatial mem-
ory performance and hippocampal neurogenesis. Injecting
adult rats with cortisol for long periods leads to similar mem-
ory impairments [40]. Lowering cortisol levels has been
found to promote neurogenesis and prevent the spatial mem-
ory impairments usually observedwith aging in rodents [41].
Humans who showed increasing 24-hour cortisol for 3 to 6
years progressing to the point of high levels were found to
have more memory impairments and smaller hippocampal
volumes [42].
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pothesis [43], which is sometimes also known as the neuro-
toxicity hypothesis. This theory suggests that chronically
elevated levels of cortisol impair HPA axis regulation, and
this dysregulated stress system leads to lower hippocampal
volume and memory deficits. Chronically elevated levels
of GCs have been shown to lead to lower dendritic branching
in the hippocampus, CA3 regional atrophy, and degeneration
of pyramidal neurons [43,44]. Moreover, studies have
suggested that chronic exposure to high GC levels after
brain insults, such as trauma or ischemia, further promote
neuronal loss [45]. AD has also been linked to higher cortisol
levels [46] and, as noted previously, lower hippocampal vol-
ume. To our knowledge, no study has yet elucidated whether
the hypercortisolemic profile causes the hippocampal vol-
ume diminution, or whether having a smaller hippocampal
volume confers vulnerability to higher secretion of cortisol.4.3. Oxidative stress
Beyond HPA axis stress, the notion of oxidative stress has
also been studied in an attempt to elucidate the mechanisms
of progression from normal to pathological aging.Mitochon-
dria produce reactive oxygen species, which can exert delete-
rious effects on body tissues. Oxidative stress occurs when
the activity of antioxidants is insufficient to counteract these
pro-oxidants [47]. Studies on a range of animal species from
rodents to nonhuman and human primates report an associa-
tion between severe life stress and oxidative stressmarkers. It
has been suggested that heightened life stressors can increase
oxidative stress, which could in turn compromise the integ-
rity of the HPA axis [47]. High oxidative stress has been
linked to cognitive impairments and AD. Oxidative stress
has been found to be associated with decreased neurogenesis
in the dentate gyrus, increased blood–brain barrier perme-
ability, neuroinflammation (see the following section),
neuronal death, and an overall higher likelihood of brain tis-
sue damage [47,48]. Neuroinflammation may in turn further
promote oxidative stress, potentially creating a vicious cycle.
Studies have shown that amyloid-beta (Ab), a neuropatho-
logical hallmark of AD, can be generated by the interaction
of oxidative stress and neuroinflammation. Both oxidative
stress and neuroinflammation have been associated with
lower telomerase activity, which in turn promotes telomere
shortening [49]. Telomere shortening is a normative process
that takes placewith aging, but excessive shortening has been
associated with cognitive impairments, increased risk of
mortality, andmultiple pathologies includingAD.Moreover,
oxidative stress increases the activity of excitatory neuro-
transmitters, notably glutamate. Sustained high levels of
oxidative stress for prolonged periods can lead to dysregu-
lated signaling processes that could result in neuronal loss,
a process called excitotoxicity [50]. This process has been re-
ported in multiple neurodegenerative diseases, including
AD. Finally, it remains important to keep inmind that chronic
stress can increase caloric intake, insulin resistance, and therisk of obesity, with consequent deleterious effects onmental
disorders [51] as well as lead to metabolic syndrome, which
has been linked with elevated levels of inflammation and AD
[52]. Although a role for oxidative stress has been suggested
from animal models of PTSD [47,53], markers of increased
oxidative stress have not reliably been linked to the actual
disorder in humans[54].4.4. Neuroinflammation and cytokines
Neuroinflammation is a process that is initiated to coun-
teract an insult to the brain. It is characterized by the activa-
tion of microglia and astrocytes, which are associated with
the release of inflammatory mediators, notably cytokines.
Cytokines mediate communication between the immune
and neuroendocrine systems. There are two distinct classes
of cytokines: pro-inflammatory and anti-inflammatory.
Stress increases the production of pro-inflammatory cyto-
kines in the periphery and in the central nervous system.
Chronically stressed individuals often have compromised
immune function and show high serum levels of pro-
inflammatory cytokines. Elevated pro-inflammatory cyto-
kines have also been reported in PTSD [55,56].
The role of chronic stress in inducing neuroinflammation
may be mediated through the release of GCs. In the brain,
GCs exert stimulate leukocyte migration. Neuroinflamma-
tion, in turn, contributes to the disruption of the normal pro-
cess of proliferation, migration, and differentiation of neural
stem cells, leading to decreased neurogenesis with impaired
new learning and memory. Findings of activated microglial
cells around amyloid plaques support a role of neuroinflam-
mation in the pathophysiology of AD [57]. In epidemiolog-
ical studies, treatment with nonsteroidal anti-inflammatory
drugs has been found to decrease AD risk [58]. Nonsteroidal
drugs have been explored as a potential treatment to delay
AD onset [58,59].
Increasing age has been associated with a change in the
immune response, with upregulation of proinflammatory
and downregulation of anti-inflammatory mediators. There
is a negative correlation between the degree of inflammation
and the age at onset of AD (i.e., the greater the degree of
inflammation, the earlier the onset). Individuals with greater
degrees of inflammation have been found to lose more points
on the MMSE during a 3-year period [60].4.5. Neuropathology
In considering stress-induced effects on neural tissue, it is
important to emphasize that not every alteration implies a
degenerative process. As with other organs of the body, the
brain is capable of changing morphologically in response
to the environment. These changes occur at molecular,
cellular, synaptic, tissue, and possibly even gross anatomical
levels, not only in neurons but also in neuroglia. Brain
changes in response to stress are numerous and vary accord-
ing to the brain region affected [61]. The most studied region
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coid cascade hypothesis is that chronically elevated levels of
cortisol can lead to dendritic atrophy in that structure [62].
Such changes have been reported in rodents and monkeys
exposed to chronic stressful situations as well as to exoge-
nous corticoids. Importantly, up to a point at least, hippo-
campal dendritic atrophy is reversible with the cessation of
stress. Also importantly, other brain areas, notably amyg-
dala, may respond to stress in the opposite direction (i.e.,
with increased dendritic proliferation and hypertrophy)
[63,64]. All these responses may be adaptive. Under
stressful environmental conditions (e.g., the constant
presence of danger), it may be advantageous to have a
hyperfunctioning amygdala, given this organ’s central role
in recognizing threat and coordinating the fear response. In
contrast, in the presence of danger, functions subserved by
the hippocampus (e.g., learning about the environment
under safe conditions and allowing behavioral flexibility)
may be disadvantageous.
The observation of regional neuronal variations in
response to stress, with atrophy in some areas but hypertro-
phy in others, precludes a simplistic assertion that stress
damages the brain. Rather, stress appears to sculpt the
brain according to the exigencies of the environment. If
the stress is prolonged, neuronal death might occur,
although recent research has challenged the constancy of
this effect [61]. In contrast to the mixed picture in stress,
a review of volumetric MRI studies showed comparable
amygdala and hippocampal volume loss in AD [65]. This
suggests a qualitative difference in the neuropathological
processes underlying stress and AD, with the former
more appropriately classified as plastic and the latter as
degenerative.
The neuropathology of AD is characterized by extracel-
lular Ab plaques and intracellular neurofibrillary tangles.
Ab is produced from the amyloid precursor protein
(APP). Tau protein is the essential ingredient of neurofibril-
lary tangles. In AD, tau protein becomes hyperphosphory-
lated, which impairs its function. Astrocytes and microglia
cluster around neurons and plaques and are activated, inter-
acting with proinflammatory molecules and disrupting the
balance between proinflammatory and anti-inflammatory
molecules [58].
Evidence in animals does suggest that stress may accel-
erate or aggravate neuropathological processes relevant to
AD. One approach is to study animals that have been
genetically modified so as to enhance pathophysiological
features associated with AD and then to examine the effect
of stress and stress hormones on them. Transgenic mice
that overexpress a mutation in APP show decreased capac-
ity for cell proliferation in the dentate gyrus. Isolation
stress has been found to accelerate the underlying process
of Ab plaque deposition in these mice [66]. In another
transgenic mouse model of AD, long-term stress was asso-
ciated with increased numbers and densities of vascular
and extracellular deposits, especially in the hippocampus,containing Ab and carboxyl-terminal fragments of APP
[67]. Exogenous administration of stress levels of glucocor-
ticoid to transgenic mice has also been found to increase Ab
formation by increasing steady-state levels of APP and
b-APP cleaving enzyme and to augment Tau protein accu-
mulation [68]. In nontransgenic Wistar rats, both stress
and glucocorticoids have been found to provoke mispro-
cessing of APP in the rat hippocampus and prefrontal cortex
[69]. In healthy, middle-agedWistar rats, chronic stress and
glucocorticoids have been found to induce abnormal hyper-
phosphorylation of Tau protein in the hippocampus and pre-
frontal cortex, with contemporaneous impairments of
hippocampal- and prefrontal cortical–dependent behaviors
[70]. For a recent, detailed review of the neuropathology of
stress, see [61].
Paradoxically, the leap from PTSD to AD may be wider
than the leap from stress to AD. Consistent with the gluco-
corticoid cascade hypothesis, in AD, as in depression,
cortisol levels tend to be high [71] and resistant to negative
feedback [72]. However, an extensive body of research has
found this not the case in PTSD; if anything, the pattern
appears to be the opposite. [4] Given that what evidence
there is that stress is involved in AD’s pathogenesis relies
heavily on a mediating role of excessive glucocorticoids, it
is difficult to apply such a model to a condition (PTSD) in
which glucocorticoids have not been found to be exces-
sive. At this point, non–glucocorticoid-mediated mecha-
nisms by which PTSD could influence AD have not been
well delineated.
Diminution of hippocampal volume is a well-replicated
finding in PTSD. Initially, this discoverywas heralded as sem-
inal evidence that stress can damage a brain structure in hu-
mans. This interpretation, however, received a setback in an
identical twin study that supported the conclusion that hippo-
campal diminution in PTSD was a constitutional abnormality
thatwas sharedbyPTSDcombat veterans’ combat-unexposed
twins [73]. Results of ameta-analysis has since revealed that a
history of exposure to traumatic events, even in the absence of
PTSD, is associated with diminished hippocampal volume
(albeit to a lesser extent than in PTSD), suggesting a causal
role for trauma exposure in hippocampal diminution [74].
However, even the very risk of exposure to trauma has genetic
determinants. Evidence that psychopharmacological treat-
ment can increase hippocampal volume inPTSD[75] suggests
but does not prove an acquired, reversible origin of the dimi-
nution. Even if a portion of the volumetric decrease found in
PTSD in hippocampus, and possibly other brain structures,
is eventually shown to be acquired rather than constitutional,
it is unclear what relevance this would have for AD and other
dementias, given that PTSD and dementia are very different
psychiatric and biological entities. The questionmight be illu-
minated by the postmortem examination of brain tissue in
PTSD in a search for AD-like changes, but few such studies
have been reported [76,77]. Until that time, any
neuropathological link between PTSD and AD remains
speculative.
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Epidemiological studies of chronic stress and PTSD have
fairly convincingly shown that both are associated with a
greater statistical risk for various forms of dementia. Howev-
er, effect sizes have generally been modest. It is clear that
neither chronic stress nor PTSD is either necessary or suffi-
cient to result in dementia. Rather, these conditions appear to
play an ancillary role among numerous factors that are
involved in the pathogenesis of dementia, including AD,
about which much remains to be discovered. Causal links
between stress and PTSD and dementia, although suggested,
have not been established. Controlling for all the potential
confounding factors is an onerous task on which progress
has been made, but more remains to be done. At the biolog-
ical level, several plausible routes from stress to dementia
have been delineated in preclinical studies, which have typi-
cally relied on animals genetically modified so as to be at
greater risk. This may have an analogy, or even homology,
in humans (i.e., stress may only increase the risk of
dementia in otherwise predisposed persons). Translation of
findings from these animal studies to human dementing
conditions has yet to be accomplished. AD has a distinctive
neuropathological profile that neither stress nor PTSD alone
has been found to produce. Although no specific anti-stress
or anti-PTSD interventions have been shown to be useful,
given the importance of the problem, further research is
called for. Meanwhile, public health interventions aimed
at reducing chronic stress and PTSD are likely to have a
salutary, if limited, effect on the risk of dementia (by what-
ever mechanism), as well as on numerous other medical
conditions.References
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